Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2084 of 5804
-
Experimental hepatitis b drug shows promise in early trial
Disease control TerminatedPatients with chronic HBV infection will receive either ARC-520 or placebo in combination with entecavir or tenofovir, and be evaluated for safety and efficacy.
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Play therapy may boost social skills in infants with tuberous sclerosis — a trial puts it to the test
Symptom relief CompletedThe investigators are running an intervention study for young children with Tuberous Sclerosis Complex (TSC). The study will include free play-based behavioral intervention that may improve social and communication skills in children with TSC. Eligible families will have a child …
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Nasal whooping cough vaccine gets a boost: higher dose tested in adults
⭐️ VACCINE ⭐️ CompletedThis study evaluates the safety and immunogenicity of a higher dose formulation of a new live attenuated vaccine, BPZE1, intended to prevent Bordetella pertussis nasopharyngeal colonization and pertussis disease, and investigates whether higher doses of BPZE1 induce the live vacc…
Phase: PHASE1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC
-
Leg movement may predict heart risk in seniors
Diagnosis OngoingBrief Summary: Current U.S. Veteran demographics reveal an aging population with significant cardiovascular dysfunction. This ultimately manifests as mobility limitation, inactivity, and a subsequent worsening of cardiovascular disease (CVD) that often leads to death. However, d…
Sponsor: VA Office of Research and Development • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
New knee implant aims to improve mobility for arthritis patients
Disease control OngoingThe purpose of this study is to evaluate the safety and effectiveness of the JOURNEY™ II CR Total Knee System in subjects with degenerative joint disease (DJD) requiring primary total knee replacement.
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Targeted drug shows promise for rare ROS1 cancers
Disease control OngoingThis phase II MATCH treatment trial identifies the effects of crizotinib in patients whose cancer has a genetic change called ROS1 translocation. Crizotinib may block a protein called ROS1, which may be needed for cancer cell growth. Researchers hope to learn if crizotinib will s…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Simple senior health quiz may predict chemo dangers
Knowledge-focused OngoingThis randomized clinical trial studies a geriatric assessment intervention in predicting chemotherapy toxicity and vulnerabilities (or weakness) in older patients with cancer. Assessing patients' functional status, comorbidities, psychological state, social support, nutritional s…
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Can an epidural pump beat IV painkillers after liver surgery?
Symptom relief OngoingThe purpose of this study is to learn whether patient-controlled epidural analgesia (PCEA) is a better method for managing pain after liver resection compared to patient-controlled analgesia (IV PCA). Currently, the standard pain control method for liver resection patients is IV …
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
What happens after cardiac arrest? new study tracks survivors for years
Knowledge-focused CompletedEarly prognosis of cardiac arrest - nearly 40000 new cases per year in France - has been extensively studied, highlighting a poor outcome (less than 8% at hospital discharge). However, little is known on mid and long-term prognostic factors and how these patients do survive from …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New Lung-Box device could save more transplant organs
Disease control CompletedThis is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against standard lung transplantation.
Phase: NA • Sponsor: Lung Bioengineering Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New cancer drug ASTX660 tested in patients with no other options
Disease control OngoingThis is an open-label, dose-escalation Phase 1/2 study to assess the safety of ASTX660, determine the maximum tolerated dose (MTD), recommended Phase 2 dose (RP2D), and recommended dosing regimen, and to obtain preliminary efficacy, pharmacokinetic (PK), and target engagement dat…
Phase: PHASE1, PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug combo shrinks prostate tumors before radiation
Disease control CompletedThe role of this study is to focus on the potential role of abiraterone acetate in treatment-naive patients newly diagnosed with high-risk localised prostate cancer requiring combined hormonal therapy and radiotherapy.
Phase: PHASE2 • Sponsor: Cancer Trials Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could your own cells fix your shoulder arthritis?
Symptom relief Recruiting nowThis is a prospective open-label clinical study of 50 patients to determine safety and treatment potential of autologous cell therapy for pain and inflammation associated with Osteoarthritis of the shoulder. Follow-up will consist of a larger sample including 4,000 patients.
Phase: PHASE2 • Sponsor: VivaTech International, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New schizophrenia drug shows promise in 6-week trial
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy, safety and tolerability of TAK-063 compared with placebo in treatment of acutely exacerbated schizophrenia.
Phase: PHASE2 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Doctor's checklist may catch more colon cancers early
Prevention CompletedObjective : to demonstrate that providing to GPs a list of their patients who are not compliant to colorectal cancer screening will 1) enhance patient participation to screening, and 2) decrease the proportion of cancer diagnosed outside the screening organisation. Design : Rando…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Real-World check: does bosutinib control CML safely?
Disease control CompletedThe objective of this surveillance is to collect information about 1. adverse drug reaction not expected from the LPD (unknown adverse drug reaction) 2. the incidence of adverse drug reactions in this surveillance 3. factors considered to affect the safety and/or efficacy of thi…
Sponsor: Pfizer • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New scan may predict chemo success in breast cancer patients
Knowledge-focused OngoingThis clinical trial studies technetium Tc-99m sestamibi molecular breast imaging in predicting tumor response in patients with locoregional breast cancer that has spread from where it began in the breast to surrounding normal tissue who are receiving neoadjuvant chemotherapy. Com…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Heart defect study tracks kids' outcomes 11 years after surgery
Knowledge-focused OngoingThe purpose of this study is to compare direct and indirect measures of right ventricular (RV) systolic and diastolic function between 11 year old subjects who had been randomly assigned to receive a right ventricle to pulmonary artery shunt (RVPAS) vs. a modified Blalock-Taussig…
Sponsor: Carelon Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New rapid test could speed up sepsis diagnosis in ER
Knowledge-focused Recruiting nowThe aim of this project is to test the utility of The Gene Z device (as of 2018 Gene Z no longer being used), now using In-Dx and other rapid identification techniques that the investigators have developed in the lab on clinically obtained bodily fluid samples taken from patients…
Sponsor: Michigan State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Can cancer treatment also kick the habit? new study tests combined approach
Disease control CompletedThis is a multicenter, interventional, randomized study among patients with a first lung or head \& neck cancer who are still active smokers ± alcohol misusers.The study will aim to compare the systematic implementation of an addiction treatment program initiated at hospital and …
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC